Core Insights - The publication of a peer-reviewed study in the Journal of Analytical Toxicology validates Omega Laboratories' method for detecting marijuana in breath samples using Cannabix Technologies' Breath Collection Unit, marking a significant advancement in marijuana breath testing technology globally [1][2] Group 1: Study Findings - The study confirms the accuracy and utility of Omega Laboratories' analytical method for detecting cannabinoids in breath samples, establishing it as a leading solution for identifying recent marijuana use [1] - Key findings include the correlation of THC metabolism trends in breath with those in blood, breath sample stability for up to 7 days, and the ability to simultaneously quantify multiple cannabinoids [1][2] - The method was validated according to ANSI/ASB Standard 036, First Edition 2019 guidelines, reinforcing its scientific credibility [1] Group 2: Industry Implications - With the expansion of medical and recreational marijuana use, the ability to detect recent cannabis consumption is increasingly critical for workplace drug testing and road safety programs [1] - The breath-based testing system offers a non-invasive alternative to traditional blood or urine tests, filling a gap in current testing methodologies [1] - The Cannabix Breath Collection Unit is positioned as a stable, consistent, and portable tool for breath collection, enhancing public safety in various applications [2] Group 3: Company Developments - Omega Laboratories and Cannabix Technologies entered a strategic partnership in May 2024 to improve the design of the Breath Collection Unit and the laboratory test method [1] - Cannabix is ramping up manufacturing of the Breath Collection Units and Breath Collection Kits, indicating a commitment to meet growing demand in safety-sensitive applications [2] - The collaboration aims to advance breath-based technology, which is essential for improving public safety in workplaces and law enforcement settings [2]

Core Insights - Cannabix Technologies Inc. has achieved a significant milestone by receiving a Validation Packet from Omega Laboratories for its Marijuana Breath Test (MBT) technology, which tests for delta-9 THC in breath samples [1][2] - The validation process confirms the capability to simultaneously quantify Δ-9-THC, Δ-8-THC, CBD, and CBN in breath aerosols, establishing Cannabix and Omega as leaders in breath testing for recent marijuana use [2][3] - The strategic partnership between Cannabix and Omega includes plans for commercialization, marketing, and distribution of the MBT, with Omega integrating Cannabix's Breath Cartridges into its services [3][4] Company Overview - Cannabix Technologies Inc. specializes in developing breath testing technologies for marijuana and alcohol, focusing on detecting recent use of delta-9 THC [7] - Omega Laboratories, based in Ohio, has over 24 years of experience in drug testing and offers advanced testing solutions to over 6,000 clients globally [5][6] - The partnership allows Omega to appoint a board member from its side, reflecting a collaborative approach to advancing the MBT technology [4]